GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Modus Therapeutics Holding AB (FRA:99Z) » Definitions » FCF Yield %

Modus Therapeutics Holding AB (FRA:99Z) FCF Yield % : -23.91 (As of Dec. 14, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Modus Therapeutics Holding AB FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Modus Therapeutics Holding AB's Trailing 12-Month Free Cash Flow is €-1.26 Mil, and Market Cap is €5.15 Mil. Therefore, Modus Therapeutics Holding AB's FCF Yield % for today is -23.91%.

The historical rank and industry rank for Modus Therapeutics Holding AB's FCF Yield % or its related term are showing as below:

FRA:99Z' s FCF Yield % Range Over the Past 10 Years
Min: -84.18   Med: 0   Max: 0
Current: -23.91


FRA:99Z's FCF Yield % is ranked worse than
62.38% of 1507 companies
in the Biotechnology industry
Industry Median: -12.96 vs FRA:99Z: -23.91

Modus Therapeutics Holding AB's FCF Margin % for the quarter that ended in Sep. 2024 was 0.00%.


Modus Therapeutics Holding AB FCF Yield % Historical Data

The historical data trend for Modus Therapeutics Holding AB's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Modus Therapeutics Holding AB FCF Yield % Chart

Modus Therapeutics Holding AB Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
FCF Yield %
- - -28.26 -55.29 -28.83

Modus Therapeutics Holding AB Quarterly Data
Dec19 Mar20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
FCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -39.31 -21.64 -42.23 -36.42 -27.53

Competitive Comparison of Modus Therapeutics Holding AB's FCF Yield %

For the Biotechnology subindustry, Modus Therapeutics Holding AB's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Modus Therapeutics Holding AB's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Modus Therapeutics Holding AB's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Modus Therapeutics Holding AB's FCF Yield % falls into.



Modus Therapeutics Holding AB FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Modus Therapeutics Holding AB's FCF Yield % for the fiscal year that ended in Dec. 2023 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=-1.492 / 5.1752016
=-28.83%

Modus Therapeutics Holding AB's annualized FCF Yield % for the quarter that ended in Sep. 2024 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=-0.35 * 4 / 5.08535435
=-27.53%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Modus Therapeutics Holding AB FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


Modus Therapeutics Holding AB FCF Yield % Related Terms

Thank you for viewing the detailed overview of Modus Therapeutics Holding AB's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Modus Therapeutics Holding AB Business Description

Traded in Other Exchanges
Address
Olof Palmes gata 29 IV, Stockholm, SWE, 111 22
Modus Therapeutics Holding AB is a Swedish clinical biotechnology company developing a treatment for sepsis, endotoxemia, severe malaria, and other disorders with severe systemic inflammation as well as states of anemia, related to chronic inflammation such as kidney diseases through its patented polysaccharide sevuparin. The drug candidate sevuparin has the opportunity to benefit patients and save large healthcare costs.

Modus Therapeutics Holding AB Headlines

No Headlines